United Therapeutics Corporation (UTHR)
UTHR: United Therapeutics Corporation Announces FDA Approval of theLungFX™ Device for Centralized Ex Vivo Lung Perfusion
UTHR: United Therapeutics Corporation Announces FDA Approval of theLungFX™ Device for Centralized Ex Vivo Lung Perfusion
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General